Sinovac Biotech Ltd (SVA) — Strategic Asset Allocation Index
Sinovac Biotech Ltd (SVA) has a Strategic Asset Allocation Index of 5.9% as of June 2024. Strategic assets (PP&E of $- plus long-term investments of $681.35 Million) total $681.35 Million, measured against net assets of $11.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Sinovac Biotech Ltd's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Sinovac Biotech Ltd Strategic Asset Allocation Index (2002–2023)
This chart shows how Sinovac Biotech Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2002 to 2023. As of June 2024, the index stands at 5.9%, representing strategic assets of $681.35 Million against net assets of $11.51 Billion USD. See SVA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Sinovac Biotech Ltd (2002–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Sinovac Biotech Ltd from 2002 to 2023, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SVA market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 5.7% | $684.28 Million | $- | $684.28 Million | $12.02 Billion | ▲ +0.5 pp |
| 2022 | 5.2% | $661.44 Million | $- | $661.44 Million | $12.71 Billion | ▲ +0.5 pp |
| 2021 | 4.7% | $655.84 Million | $- | $655.84 Million | $13.88 Billion | ▼ -20.6 pp |
| 2020 | 25.4% | $284.20 Million | $284.20 Million | $0.00 | $1.12 Billion | ▲ +2.4 pp |
| 2019 | 23.0% | $80.95 Million | $80.95 Million | $- | $352.19 Million | ▼ -1.3 pp |
| 2018 | 24.3% | $70.92 Million | $70.92 Million | $0.00 | $291.93 Million | ▼ -34.7 pp |
| 2017 | 58.9% | $76.43 Million | $76.43 Million | $0.00 | $129.67 Million | ▲ +7.4 pp |
| 2016 | 51.6% | $66.88 Million | $66.88 Million | $0.00 | $129.67 Million | ▲ +4.8 pp |
| 2015 | 46.8% | $63.91 Million | $63.91 Million | $0.00 | $136.50 Million | ▼ -1.5 pp |
| 2014 | 48.3% | $68.42 Million | $68.42 Million | $- | $141.73 Million | ▲ +1.0 pp |
| 2013 | 47.3% | $67.96 Million | $67.96 Million | $- | $143.64 Million | ▼ -14.6 pp |
| 2012 | 61.9% | $80.08 Million | $80.08 Million | $- | $129.44 Million | ▲ +9.8 pp |
| 2011 | 52.1% | $75.63 Million | $75.63 Million | $- | $145.30 Million | ▲ +8.7 pp |
| 2010 | 43.3% | $64.04 Million | $64.04 Million | $- | $147.76 Million | ▲ +16.9 pp |
| 2009 | 26.4% | $22.31 Million | $22.31 Million | $- | $84.47 Million | ▼ -9.5 pp |
| 2008 | 35.9% | $19.26 Million | $19.26 Million | $- | $53.64 Million | ▼ -12.3 pp |
| 2007 | 48.3% | $15.88 Million | $15.88 Million | $- | $32.90 Million | ▼ -12.9 pp |
| 2006 | 61.1% | $13.03 Million | $13.03 Million | $- | $21.31 Million | ▼ -14.3 pp |
| 2005 | 75.5% | $12.46 Million | $12.46 Million | $- | $16.51 Million | ▲ +10.9 pp |
| 2004 | 64.5% | $10.04 Million | $10.04 Million | $- | $15.56 Million | ▼ -4.0 pp |
| 2003 | 68.5% | $7.46 Million | $7.46 Million | $- | $10.89 Million | ▲ +61.5 pp |
| 2002 | 7.0% | $7.00K | $7.00K | $- | $99.44K | — |